Trafford Clarke
Independent DirectorDr. Trafford Clarke, Ph.D. is Mentor of MIT Sandbox Innovation Fund Program. Dr. Clarke is Independent Director of Traws Pharma, Inc. (formerly known as Onconova Therapeutics, Inc.) from December 15, 2022. He is a pharmaceutical industry veteran who has dedicated his career to the discovery, development and launch of new medicines. He spent years working in roles of increasing responsibility at Eli Lilly and Company before retiring in 2017, he served as a Managing Director and UK Research and Development Site Head from 2013 to 2017. In this role, Dr. Clarke led a team of approximately 700 people and oversaw site productivity, infrastructure investment and ethics and compliance standards. In addition, from 2013 to 2017, as Eli Lilly's European Federation of Pharmaceutical Industries and Associations R&D representative, Dr. Clarke was a member of the Research Directors Group and championed Lilly's strategic engagement and leadership of 32 European Union Innovative Medicine Initiative projects. From 2013 to 2017, he served as Board Member for Eli Lilly and Company Ltd. UK and was a member of the Innovation Board of the Association of the British Pharmaceutical Industry. From 2020 to present, Dr. Clarke served as a mentor to student entrepreneurs at the MIT Sandbox Innovation Fund Program and he also serves on the board of the non-profit Barrier Islands Free Medical Clinic. Dr. Clarke has a Ph.D. in organic chemistry from Imperial College, London and a Bachelor of Science in organic chemistry from University of Liverpool.
Positions
- Company NameTraws Pharma, Inc.Stock CodeTRAWPositionIndependent DirectorColleagues
